HOSPITALIZATION COSTS RELATED TO PULMONARY HYPERTENSION (PH) AMONG MEDICARE ADVANTAGE OR COMMERCIALLY INSURED PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN THE UNITED STATES

被引：3
|
作者：
Lacey, M. [1 ]
Hunsche, E. [2 ]
Buzinec, P. [1 ]
Drake, W. [3 ]
Nagao, M. [3 ]
Regulier, E. [2 ]
机构：
[1] OptumInsight, Eden Prairie, MN USA
[2] Actel Pharmaceut Ltd, Allschwil, Switzerland
[3] Actel Pharmaceut US Inc, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1184
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [21] The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States
    Rice, J. Bradford
    White, Alan G.
    Galebach, Philip
    Korenblat, Kevin M.
    Wagh, Aneesha
    Lovelace, Belinda
    Wan, George J.
    Jamil, Khurram
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (08) : 1473 - 1480
  • [22] IN-FLIGHT HYPOXAEMIA IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH)
    Burns, R. M.
    Peacock, A. J.
    Johnson, M. K.
    Church, A. C.
    THORAX, 2011, 66 : A67 - A67
  • [23] Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers
    Ferrari, Pisana
    Armstrong, Iain
    Aldrighetti, Rino
    Howard, Luke
    Ryftenius, Henrik
    Fischer, Aryeh
    Lombardi, Sandra
    Studer, Sean
    Guillevin, Loic
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [24] Commentary on Symptom Experience of Pulmonary Arterial Hypertension (PAH) Patients
    Khan, Ehsan Ullah
    CLINICAL NURSING RESEARCH, 2011, 20 (02) : 135 - 143
  • [25] Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study
    Hoeper, Marius M.
    Corris, Paul A.
    Ghofrani, Hossein-Ardeschir
    Klinger, James R.
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond L.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [26] Effect of Riociguat on Pulmonary Arterial Compliance in Patients With Pulmonary Arterial Hypertension (PAH) in the Respite Study
    Thenappan, Thenappan
    Hoeper, Marius
    Corris, Paul
    Ghofrani, Hossein-Ardeschir
    Klinger, James
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond
    CHEST, 2017, 152 (04) : 1005A - 1006A
  • [27] Treatment Patterns After Initial Therapy Among Pulmonary Arterial Hypertension Patients In The United States
    Burger, C. D.
    Ozbay, B.
    Riehle, E.
    Lenhart, G.
    White, R. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [28] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE UNITED STATES
    Pizzicato, Lia
    Nadipelli, Vijay R.
    Samuel, Governor
    Mao, Jianbin
    Lanes, Stephan
    Butler, John
    Pepe, Rebecca S.
    Phatak, Hemant
    El-Kersh, Karim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1677 - 1677
  • [29] ECONOMIC BURDEN OF HOSPITALIZATIONS RELATED TO PULMONARY ARTERIAL HYPERTENSION (PAH) IN FRANCE
    Bergot, E.
    de Leotoing, L.
    Bendjenana, H.
    Tournier, C.
    Vainchtock, A.
    Nachbaur, G.
    Humbert, M.
    VALUE IN HEALTH, 2017, 20 (09) : A609 - A610
  • [30] COSTS OF BREAST CANCER RELATED CARE AMONG WOMEN IN THE UNITED STATES INSURED COMMERCIALLY, AND BY MEDICARE AND MEDICAID - A SYSTEMATIC REVIEW
    Lingohr-Smith, M.
    Deitelzweig, C.
    Menges, B. L.
    Lin, G.
    VALUE IN HEALTH, 2017, 20 (05) : A102 - A102
12345